Daniel Feikin: Difference between revisions
Content deleted Content added
BOT--Reverting link addition(s) by Barbjhsph to revision 448807264 (http://www.youtube.com/watch?v=-EVDJr_1NYw) |
|||
| (41 intermediate revisions by 27 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|American epidemiologist}} |
|||
{{BLP unsourced|date=September 2011}} |
|||
'''Daniel Feikin''' is |
'''Daniel R. Feikin''' (born {{abbr|c.|circa}} 1965) is an American [[epidemiology|epidemiologist]]. He specializes in the epidemiology of [[infectious disease]]s in developing countries. He currently serves as Director of Epidemiology at the International Vaccine Access Center (IVAC), an organization dedicated to increasing global access to vaccines, at the [[Johns Hopkins Bloomberg School of Public Health]] in [[Baltimore, Maryland]].<ref>[http://www.jhsph.edu/ivac IVAC | International Vaccine Access Center | Johns Hopkins Bloomberg School of Public Health<!-- Bot generated title -->]</ref> He earlier worked at the National Centers for Infectious Diseases, [[Centers for Disease Control and Prevention]], [[Atlanta, Georgia]].<ref>{{cite journal | url=http://www.sciencedirect.com/science/article/pii/S0140673605669127 | doi=10.1016/S0140-6736(05)66912-7 | pmid=16023513 | date=2005 | last1=Luby | first1=S. P. | last2=Agboatwalla | first2=M. | last3=Feikin | first3=D. R. | last4=Painter | first4=J. | last5=Billhimer | first5=W. | last6=Altaf | first6=A. | last7=Hoekstra | first7=R. M. | title=Effect of handwashing on child health: A randomised controlled trial | journal=Lancet | volume=366 | issue=9481 | pages=225–233 }}</ref> While working for the CDC he lived for a time in [[Kisumu]], [[Kenya]], from which he and his family had to be evacuated in 2008 due to local violence.<ref>[https://www.nytimes.com/2008/02/24/magazine/24lives-t.html Feikin, Daniel, ''Out of Kisumu''], New York Times Magazine, February 24, 2008</ref> |
||
== Education == |
== Education == |
||
Feikin earned his M.D. degree at [[Harvard Medical School]]. He also earned a Master of Science in Public Health from the [[University of Colorado Health Sciences Center]] and a bachelor's degree from [[Yale University]].<ref>{{Cite web |title=Daniel Ross Feikin, MD |url=https://publichealth.jhu.edu/faculty/2313/daniel-ross-feikin |access-date=2023-03-07 |website=Johns Hopkins Bloomberg School of Public Health |language=en}}</ref> |
|||
== Research == |
|||
After completing his residency in Internal Medicine, Dr. Feikin worked for the Centers for Disease Control and Prevention (CDC), first as an Epidemic Intelligence Service Officer for 2 years and then as a Medical Epidemiologist in the Respiratory Disease Branch in the Division of Bacterial and Mycotic Diseases for 4 years. While at the CDC, Dr. Feikin’s subject matter concentration was on respiratory bacteria, particularly accelerating and evaluating the impact of vaccines for Haemophilus influenzae type b and Streptococcus pneumoniae. In 2004, Dr. Feikin served as Epidemiology Section Chief for the International Emerging Infections Program in Kenya. In that role, he conducted outbreak investigations of infectious diseases in Kenya (cholera, meningococcal meningitis, Rift Valley Fever, Brucella, Typhoid Fever), coordinated longitudinal, population-based surveillance for infectious diseases in rural and urban Kenya, coordinated health aspects of Demographic Surveillance System, and was a principal investigator on clinical trials of rotavirus vaccine and home zinc treatment for diarrhea. |
|||
Currently, at IVAC Dr. Feikin has been developing the Pneumonia Etiology Research for Child Health (PERCH) project, which is funded by a 43 million dollar grant from the Bill and Melinda Gates Foundation. The PERCH research study aims to identify etiology of severe pneumonia in children in developing countries in the post-Hib/pneumococcal vaccine era. Dr. Feikin is the lead on the clinical/epidemiology team. Dr. Feikin also is the principal investigator at IVAC on a systematic review of available data on the issue of serotype replacement after introduction of pneumococcal conjugate vaccines. The results of this project will contribute to a new WHO position paper on pneumococcal vaccines for developing countries. Dr. Feikin is also working on the Accelerated Vaccine Initiative to evaluate the impact of introduction of pneumococcal conjugate, Haemophilus influenza type b and rotavirus vaccines in the world’s poorest countries. |
|||
Dr. Feikin has co-authored over 70 peer-reviewed publications, several dozen non-peer-reviewed publications and 2 book chapters. |
|||
== Honors and Awards == |
|||
{| |
|||
|- |
|||
| 1987 || Yale University: summa cum laude; Phi Beta Kappa; |
|||
Allan Bateman Prize for Outstanding Science Student in Silliman College; |
|||
William B. Belknap Prize for Excellence in Biology; |
|||
Silliman College Student Marshall |
|||
|- |
|||
| 1998 || Mackel Award finalist, first author. EIS conference, Atlanta, Georgia |
|||
|- |
|||
| 2000 || Mackel Award finalist, co-author. EIS conference, Atlanta, Georgia |
|||
|- |
|||
| 2004 || James H. Nakano citation. Outstanding scientific paper published in 2003. National Center for Infectious Diseases, CDC |
|||
|- |
|||
| 2004 || 2004 NCEH/ATSDR Honor Award for Excellence in Global Efforts. Aflatoxin Outbreak. |
|||
|- |
|||
| 2006 || James H. Nakano citation. Outstanding scientific paper published in 2003. National Center for Infectious Diseases, CDC |
|||
|- |
|||
| 2006 || Charles C. Shepard Science Award for Scientific Excellence demonstrated by publication of Paper on effect of handwashing on child health. CDC. |
|||
|- |
|||
| 1996-present || US Public Health Service awards include Achievement Medal (2), Citation (1), Outstanding Unit Commendation (1), Unit Commendation (2), Outstanding Unit citation (2), Crisis Response Service Award (1), Foreign Duty Award (2), Outstanding Service Medal (1) |
|||
|} |
|||
== References == |
== References == |
||
<!--- See [[Wikipedia:Footnotes]] on how to create references using <ref></ref> tags which will then appear here automatically --> |
|||
{{Reflist}} |
{{Reflist}} |
||
== External links == |
== External links == |
||
* [http://www.jhsph.edu/faculty/directory/profile/5257/daniel-feikin Website at Johns Hopkins Bloomberg School of Public Health] |
|||
* [http://www.example.com/ example.com] |
|||
* [http://www.jhsph.edu/ivac International Vaccine Access Center] |
|||
* [https://pubmed.ncbi.nlm.nih.gov/?term=Feikin+DR&cauthor_id=22078723 PubMed search for Daniel R. Feikin] |
|||
{{DEFAULTSORT:Feikin, Daniel}} |
|||
<!--- Categories ---> |
<!--- Categories ---> |
||
[[Category: |
[[Category:American epidemiologists]] |
||
[[Category:Harvard Medical School alumni]] |
|||
[[Category:University of Colorado alumni]] |
|||
[[Category:Yale University alumni]] |
|||
[[Category:Johns Hopkins Hospital physicians]] |
|||
[[Category:1960s births]] |
|||
[[Category:Living people]] |
|||
Latest revision as of 06:15, 11 June 2024
Daniel R. Feikin (born c. 1965) is an American epidemiologist. He specializes in the epidemiology of infectious diseases in developing countries. He currently serves as Director of Epidemiology at the International Vaccine Access Center (IVAC), an organization dedicated to increasing global access to vaccines, at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.[1] He earlier worked at the National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.[2] While working for the CDC he lived for a time in Kisumu, Kenya, from which he and his family had to be evacuated in 2008 due to local violence.[3]
Education
[edit]Feikin earned his M.D. degree at Harvard Medical School. He also earned a Master of Science in Public Health from the University of Colorado Health Sciences Center and a bachelor's degree from Yale University.[4]
References
[edit]- ^ IVAC | International Vaccine Access Center | Johns Hopkins Bloomberg School of Public Health
- ^ Luby, S. P.; Agboatwalla, M.; Feikin, D. R.; Painter, J.; Billhimer, W.; Altaf, A.; Hoekstra, R. M. (2005). "Effect of handwashing on child health: A randomised controlled trial". Lancet. 366 (9481): 225–233. doi:10.1016/S0140-6736(05)66912-7. PMID 16023513.
- ^ Feikin, Daniel, Out of Kisumu, New York Times Magazine, February 24, 2008
- ^ "Daniel Ross Feikin, MD". Johns Hopkins Bloomberg School of Public Health. Retrieved 2023-03-07.